The compound state: Hb S/beta-thalassemia

Revista Brasileira de Hematologia e Hemoterapia

Volumn 37, Issue 3, 2015, Pages 150-152

  Figueiredo, Maria Stella ^a  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN A2;

CELL DIFFERENTIATION; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; DNA POLYMORPHISM; GENE MUTATION; GENETIC ANALYSIS; HEMATOCRIT; HEMOLYSIS; HUMAN; MEAN CORPUSCULAR VOLUME; MICROCYTOSIS; MOLECULAR DIAGNOSIS; NOTE; QUANTITATIVE ANALYSIS; SICKLE CELL BETA THALASSEMIA;

EID: 84930090789     PISSN: 15168484     EISSN: 18060870     Source Type: Journal    
DOI: 10.1016/j.bjhh.2015.02.008     Document Type: Note

References (16)

1. Rees D.C., Gibson J.S. Biomarkers in sickle cell disease. Br J Haematol 2012, 156(4):433-445.
2. Stuart M.J., Nagel R.L. Sickle-cell disease. Lancet 2004, 364(9442):1343-1360.
3. Dacie J. The hereditary haemolytic anaemias 1988, Churchill Livingstone, New York. 3rd ed.
4. Thein S.L. Genetic modifiers of sickle cell disease. Hemoglobin 2011, 35(5-6):589-606.
5. Steinberg M.H. Compound heterozygous and other sickle hemoglobinopathies. Disorders of hemoglobin: genetics, pathophysiology, and clinical management 2001, 786-810. Cambridge University Press, Cambridge, UK. 1st ed. M.H. Steinberg, B.G. Forget, D.R. Higgs, R.L. Nagel (Eds.).
6. Forget B.G., Bunn H.F. Classification of the disorders of hemoglobin. Cold Spring Harb Perspect Med 2013, 3(2):a011684.
7. Rigano P., Rodgers G.P., Renda D., Renda M.C., Aquino A., Maggio A. Clinical and hematological responses to hydroxyurea in Sicilian patients with Hb S/beta-thalassemia. Hemoglobin 2001, 25(1):9-17.
8. Schmugge M., Waye J.S., Basran R.K., Zurbriggen K., Frischknecht H. The Hb S/beta+-thalassemia phenotype demonstrates that the IVS-I (-2) (A>C) mutation is a mild beta-thalassemia allele. Hemoglobin 2008, 32(3):303-307.
9. Lacan P., Ponceau B., Aubry M., Francina A. Mild Hb S-beta(+)-thalassemia with a deletion of five nucleotides at the polyadenylation site of the beta-globin gene. Hemoglobin 2003, 27(4):257-259.
10. Boletini E., Svobodova M., Divoky V., Baysal E., Curuk M.A., Dimovski A.J., et al. Sickle cell anemia, sickle cell beta-thalassemia, and thalassemia major in Albania: characterization of mutations. Hum Genet 1994, 93(2):182-187.
11. Gonzalez-Redondo J.M., Kutlar A., Kutlar F., McKie V.C., McKie K.M., Baysal E., et al. Molecular characterization of Hb S(C) beta-thalassemia in American blacks. Am J Hematol 1991, 38(1):9-14.
12. Divoky V., Baysal E., Schiliro G., Dibenedetto S.P., Huisman T.H. A mild type of Hb S-beta(+)-thalassemia [-92(C→T)] in a Sicilian family. Am J Hematol 1993, 42(2):225-226.
13. Kinney T.R., Ware R.E. Compound heterozygous states. Sickle cell disease: basic principles and clinical practice 1994, 437-451. Raven Press Ltd., New York. 1st ed. S.H. Embury, R.P. Hebbel, N. Mohandas, M.H. Steinberg (Eds.).
14. Serjeant G.R., Serjeant B.E., Fraser R.A., Hambleton I.R., Higgs D.R., Kulozik A.E., et al. Hb S-beta-thalassemia: molecular, hematological and clinical comparisons. Hemoglobin 2011, 35(1):1-12.
15. Serjeant G.R. The natural history of sickle cell disease. Cold Spring Harb Perspect Med 2013, 3(10):a011783.
16. Belisario A.R., Sales R.R., Viana M.B. Very mild forms of Hb S/beta+-thalassemia in Brazilian children. Rev Bras Hematol Hemoter 2015, 37(3):198-201.